{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,3]],"date-time":"2026-04-03T19:20:16Z","timestamp":1775244016482,"version":"3.50.1"},"reference-count":21,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,1,1]],"date-time":"2018-01-01T00:00:00Z","timestamp":1514764800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,1,1]],"date-time":"2018-01-01T00:00:00Z","timestamp":1514764800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2018,2,28]],"date-time":"2018-02-28T00:00:00Z","timestamp":1519776000000},"content-version":"vor","delay-in-days":58,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"name":"Basilea Pharmaceutica International Ltd."}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["IDCases"],"published-print":{"date-parts":[[2018]]},"DOI":"10.1016\/j.idcr.2018.02.011","type":"journal-article","created":{"date-parts":[[2018,3,1]],"date-time":"2018-03-01T08:01:33Z","timestamp":1519891293000},"page":"7-9","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"special_numbering":"C","title":["Issues in the management of invasive pulmonary aspergillosis in non-neutropenic patients in the intensive care unit: A role for isavuconazole"],"prefix":"10.1016","volume":"12","author":[{"given":"Matteo","family":"Bassetti","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alessia","family":"Carnelutti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8718-1200","authenticated-orcid":false,"given":"Elda","family":"Righi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"suppl. 1","key":"10.1016\/j.idcr.2018.02.011_bib0005","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1093\/jac\/dkx032","article-title":"Invasive mould infections in the ICU setting: complexities and solutions","volume":"72","author":"Bassetti","year":"2017","journal-title":"J Antimicrob Chemother"},{"issue":"5","key":"10.1016\/j.idcr.2018.02.011_bib0010","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1086\/505870","article-title":"Comparison of epidemiological, clinical, and biological features of invasive aspergillosis in neutropenic and nonneutropenic patients: a 6-year survey","volume":"43","author":"Cornillet","year":"2006","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.idcr.2018.02.011_bib0015","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1111\/j.1749-6632.2012.06805.x","article-title":"Invasive aspergillosis in the intensive care unit","volume":"1272","author":"Dimopoulos","year":"2012","journal-title":"Ann NY Acad Sci"},{"issue":"6","key":"10.1016\/j.idcr.2018.02.011_bib0020","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1164\/rccm.200401-093OC","article-title":"Invasive aspergillosis in critically ill patients without malignancy","volume":"170","author":"Meersseman","year":"2004","journal-title":"Am J Respir Crit Care Med"},{"issue":"9","key":"10.1016\/j.idcr.2018.02.011_bib0025","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.1086\/592255","article-title":"Factors associated with overall and attributable mortality in invasive aspergillosis","volume":"47","author":"Nivoix","year":"2008","journal-title":"Clin Infect Dis"},{"issue":"12","key":"10.1016\/j.idcr.2018.02.011_bib0030","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.1086\/588660","volume":"46","author":"De Pauw","year":"2008","journal-title":"Clin Infect Dis"},{"issue":"3","key":"10.1016\/j.idcr.2018.02.011_bib0035","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.ijantimicag.2014.05.019","article-title":"Voriconazole pharmacokinetics and exposure-response relationships: assessing the links between exposure, efficacy and toxicity","volume":"44","author":"Dolton","year":"2014","journal-title":"Int J Antimicrob Agents"},{"issue":"12","key":"10.1016\/j.idcr.2018.02.011_bib0040","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1016\/j.medmal.2011.09.016","article-title":"Phototoxicity and photocarcinogenesis associated with voriconazole","volume":"41","author":"Epaulard","year":"2011","journal-title":"Med Mal Infect"},{"issue":"July","key":"10.1016\/j.idcr.2018.02.011_bib0045","article-title":"Drug-drug interactions between triazole antifungal agents used to treat invasive aspergillosis and immunosuppressants metabolized by cytochrome P 450 3A4","author":"Groll","year":"2017","journal-title":"Transpl Infect Dis"},{"key":"10.1016\/j.idcr.2018.02.011_bib0050","series-title":"Update of the ECIL guidelines for antifungal treatment in leukemia and HSCT patients","author":"Herbrecht","year":"2013"},{"issue":"4","key":"10.1016\/j.idcr.2018.02.011_bib0055","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1093\/cid\/ciw326","article-title":"Practice guidelines for the diagnosis and management of aspergillosis: 2016 update by the Infectious Diseases Society of America","volume":"63","author":"Patterson","year":"2016","journal-title":"Clin Infect Dis"},{"issue":"10020","key":"10.1016\/j.idcr.2018.02.011_bib0060","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1016\/S0140-6736(15)01159-9","article-title":"Isavuconazole versus voriconazole for primary treatment of invasive mould disease caused by Aspergillus and other filamentous fungi (SECURE): a phase 3, randomised-controlled, non-inferiority trial","volume":"387","author":"Maertens","year":"2016","journal-title":"Lancet"},{"issue":"6","key":"10.1016\/j.idcr.2018.02.011_bib0065","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1002\/cpt.620","article-title":"QT interval shortening with isavuconazole: in vitro and in vivo effects on cardiac repolarization","volume":"101","author":"Keirns","year":"2017","journal-title":"Clin Pharmacol Ther"},{"issue":"1","key":"10.1016\/j.idcr.2018.02.011_bib0070","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1164\/rccm.201111-1978OC","article-title":"A clinical algorithm to diagnose invasive pulmonary aspergillosis in critically ill patients","volume":"186","author":"Blot","year":"2012","journal-title":"Am J Respir Crit Care Med"},{"issue":"1","key":"10.1016\/j.idcr.2018.02.011_bib0075","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1164\/rccm.200704-606OC","article-title":"Galactomannan in bronchoalveolar lavage fluid: a tool for diagnosing aspergillosis in intensive care unit patients","volume":"177","author":"Meersseman","year":"2008","journal-title":"Am J Respir Crit Care Med"},{"issue":"9","key":"10.1016\/j.idcr.2018.02.011_bib0080","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1007\/s00228-017-2284-5","article-title":"Voriconazole-induced QT prolongation among hemato-oncologic patients: clinical characteristics and risk factors","volume":"73","author":"Gueta","year":"2017","journal-title":"Eur J Clin Pharmacol"},{"issue":"3","key":"10.1016\/j.idcr.2018.02.011_bib0085","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1128\/AAC.00958-12","article-title":"Effect of combined fluoroquinolone and azole use on QT prolongation in hematology patients","volume":"57","author":"Zeuli","year":"2013","journal-title":"Antimicrob Agents Chemother"},{"issue":"3","key":"10.1016\/j.idcr.2018.02.011_bib0090","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1007\/s12245-008-0052-0","article-title":"Torsade de pointes caused by polypharmacy and substance abuse in a patient with human immunodeficiency virus","volume":"1","author":"Prosser","year":"2008","journal-title":"Int J Emerg Med"},{"key":"10.1016\/j.idcr.2018.02.011_bib0095","unstructured":"Cresemba Prescribing Information, Basilea Pharmaceutica International Ltd (June 2015)."},{"issue":"13","key":"10.1016\/j.idcr.2018.02.011_bib0100","doi-asserted-by":"crossref","first-page":"1300","DOI":"10.1016\/j.jacc.2013.09.078","article-title":"Novel insight into the natural history of short QT syndrome","volume":"63","author":"Mazzanti","year":"2014","journal-title":"J Am Coll Cardiol"},{"issue":"2","key":"10.1016\/j.idcr.2018.02.011_bib0105","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1128\/AAC.01123-08","article-title":"Comprehensive in vitro analysis of voriconazole inhibition of eight cytochrome P450 (CYP) enzymes: major effect on CYPs 2B6, 2C9, 2C19, and 3A","volume":"53","author":"Jeong","year":"2009","journal-title":"Antimicrob Agents Chemother"}],"container-title":["IDCases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2214250918300192?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2214250918300192?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T12:01:51Z","timestamp":1761998511000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2214250918300192"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018]]},"references-count":21,"alternative-id":["S2214250918300192"],"URL":"https:\/\/doi.org\/10.1016\/j.idcr.2018.02.011","relation":{},"ISSN":["2214-2509"],"issn-type":[{"value":"2214-2509","type":"print"}],"subject":[],"published":{"date-parts":[[2018]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Issues in the management of invasive pulmonary aspergillosis in non-neutropenic patients in the intensive care unit: A role for isavuconazole","name":"articletitle","label":"Article Title"},{"value":"IDCases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.idcr.2018.02.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}